hydrazine has been researched along with Purpura, Thrombopenic in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 3 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| Gu, C; Kong, D; Li, Y; Tian, H; Wang, Z; Wu, D; Yin, J; Yu, Z | 1 |
| Al-Samkari, H; Park, AK; Park, JC | 1 |
| Maeda, Y; Tamai, Y; Yamamoto, D | 1 |
| Fang, L; Hussaini, A; Kleha, JF; Theodore, D; Wire, MB | 1 |
| Birgens, H; Brown, Pde N; Dalseg, AM; Dufva, IH; Hasselbalch, HC; Jensen, MK; Vangsted, A | 1 |
| Cela, I; Katz, RS; Miller, IJ; Rizman, A; Shammo, JM | 1 |
| Bosworth, J; Lown, R; Rhodes, E; Shannon, MS; Stasi, R | 1 |
| Fujita, S; Hotta, M; Ishii, K; Ito, T; Nakamichi, N; Nakanishi, T; Nomura, S; Tamaki, T; Yoshimura, H | 1 |
2 review(s) available for hydrazine and Purpura, Thrombopenic
| Article | Year |
|---|---|
[Novel medical treatment modalities in hematology].
Topics: Aminoglycosides; Anemia, Hemolytic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Benzamides; Benzoates; Boronic Acids; Bortezomib; Carbazoles; Carrier Proteins; Cyclophosphamide; Dasatinib; Furans; Gemtuzumab; Hematologic Diseases; Humans; Hydrazines; Imatinib Mesylate; Immunologic Factors; Indoles; Lenalidomide; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Lymphoma; Multiple Myeloma; Myelodysplastic Syndromes; Piperazines; Purpura, Thrombocytopenic; Pyrazines; Pyrazoles; Pyrimidines; Receptors, Fc; Recombinant Fusion Proteins; Rituximab; Thalidomide; Thiazoles; Thrombopoietin; Vidarabine | 2008 |
Acquired amegakaryocytic thrombocytopenia: potential role of thrombopoietin receptor agonists.
Topics: Benzoates; Bone Marrow Diseases; Humans; Hydrazines; Purpura, Thrombocytopenic; Pyrazoles; Receptors, Fc; Receptors, Thrombopoietin; Recombinant Fusion Proteins; Salvage Therapy; Thrombopoietin | 2010 |
2 trial(s) available for hydrazine and Purpura, Thrombopenic
| Article | Year |
|---|---|
Lack of clinically significant pharmacokinetic interaction between the thrombopoietin receptor agonist eltrombopag and hepatitis C virus protease inhibitors boceprevir and telaprevir.
Topics: Adult; Area Under Curve; Benzoates; Calcium; Cross-Over Studies; Diet; Drug Interactions; Female; Healthy Volunteers; Hepacivirus; Hepatitis C, Chronic; Humans; Hydrazines; Male; Middle Aged; Oligopeptides; Proline; Purpura, Thrombocytopenic; Pyrazoles; Receptors, Thrombopoietin; Serine Proteinase Inhibitors; Young Adult | 2014 |
TGFβ(1) and sCTLA-4 levels are increased in eltrombopag-exposed patients with ITP.
Topics: Benzoates; CTLA-4 Antigen; Dose-Response Relationship, Drug; Female; Humans; Hydrazines; Male; Middle Aged; Purpura, Thrombocytopenic; Pyrazoles; Receptors, Thrombopoietin; Transforming Growth Factor beta1; Treatment Outcome | 2012 |
4 other study(ies) available for hydrazine and Purpura, Thrombopenic
| Article | Year |
|---|---|
Successful treatment of acquired amegakaryocytic thrombocytopenia with eltrombopag and immunosuppressant.
Topics: Benzoates; Bone Marrow Diseases; Humans; Hydrazines; Immunoglobulins, Intravenous; Immunosuppressive Agents; Purpura, Thrombocytopenic; Pyrazoles; Thrombopoietin | 2022 |
Pembrolizumab-Induced Acquired Amegakaryocytic Thrombocytopenia and Successful Combination Treatment With Eltrombopag, Romiplostim and Cyclosporine: A Brief Communication.
Topics: Antibodies, Monoclonal, Humanized; Benzoates; Bone Marrow Diseases; Communication; Cyclosporine; Humans; Hydrazines; Purpura, Thrombocytopenic; Pyrazoles; Receptors, Fc; Recombinant Fusion Proteins; Thrombopoietin | 2022 |
Eltrombopag-induced recurrent stroke in idiopathic thrombocytopenic purpura.
Topics: Benzoates; Humans; Hydrazines; Purpura, Thrombocytopenic; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Stroke | 2021 |
Successful treatment of amegakaryocytic thrombocytopenia with eltrombopag in a patient with systemic lupus erythematosus (SLE).
Topics: Benzoates; Blood Platelets; Bone Marrow Diseases; Female; Humans; Hydrazines; Lupus Erythematosus, Systemic; Megakaryocytes; Middle Aged; Molecular Mimicry; Purpura, Thrombocytopenic; Pyrazoles; Receptors, Thrombopoietin; Remission Induction; Treatment Outcome | 2010 |